Guaifenesin and Dextromethorphan Oral Solution
- Manufacturer
- Major Pharmaceuticals | Plastikon Healthcare, LLC
- Effective date
- 2021-12-17
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 22:22:16
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
Guaifenesin Dextromethorphan hydrobromide 100/10 mg/5 mL Cup
NCD 0904-6844-70
Guaifenesin and Detromethorphan Oral Solution
100-10 mg/5 mL
Delivers 5 mL
See Insert
For Institutional Use Only
MAJOR® PHARMACEUTICALS
Livonia, MI 48152
Sugar Free - Alcohol Free
Guaifenesin Dextromethorphan hydrobromide 100/10 mg/5 mL cup
Directions
- do not exceed the maximum recommended daily dose in a 24 hour period
- shake well before use
Age (yr) | Dose (mL) |
adults and children 12 years and over | 10 mL every 4 hours or 15 mL every 6 hours Max dose is 60 mL in 24 hr |
children 6 years to under 12 years | 5 mL every 4 hours Max does is 30 mL in 24 hr |
under 6 years | Ask a doctor |
Guaifenesin Dextromethorphan hydrobromide 100/10 mg/5 mL
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
Guaifenesin Dextromethorphan hydrobromide 100/10 mg/5 mL
Guaifenesin Dextromethorphan hydrobromide 100/10 mg/5 mL
Warnings
Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) or for 2 weeks after stopping the MAOI drug.
Ask a doctor before use if you have
- cough that occurs with too much phlegm (mucus)
- cough that lasts or is chronic such as occurs with smoking, asthma, chronic bronchitis, or emphysema
_________________________________________________________________
Ask a doctor or pharmacist before use if you are taking any other drug. ___________________________________________________________________
Stop use and ask a doctor if
- your cough lasts more than 7 days, comes back, or is accompanied by fever, rash or persistent headache.
Guaifenesin Dextromethorphan hydrobromide 100/10 mg/ 5 mL
Inactive ingredients citric acid, glycerin, propylene glycol, purified water, saccharin sodium, sodium benzoate, sorbitol, sucralose, xanthan gum
Guaifenesin Dextromethorphan hydrobromide 100/10 mg/ 5 mL
Uses
- helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive
- temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold.
Guaifenesin Dextromethorphan hydrobromide 100/10 mg/5 mL
Active ingredients (in each 5 mL cup)
Guaifenesin 100 mg
Dextromethorphan hydrobromide 10 mg
Guaifenesin Dextromethorphan hydrobromide 100/10 mg/5 mL
Purpose
Expectorant
Cough Suppressant
Guaifenesin Dextromethorphan hydrobromide 100/10 mg/ 5 mL
Other information
- each 5 mL contains: sodium 20 mg
- store at 20-25°C (68-77°F)
- protect from excessive moisture
- do not use if lid seal is open or damaged
- sugar free, dye free, alcohol free
- see bottom of cup for lot number and expiration date
Guaifenesin Dextromethorphan hydrobromide 200/20 mg/10mL
NCD 0904-6980-72
Guaifenesin and Detromethorphan Oral Solution
200-20 mg/10 mL
Delivers 10 mL
See Insert
For Institutional Use Only
MAJOR® PHARMACEUTICALS
Livonia, MI 48152
Sugar Free - Alcohol Free
Guaifenesin Dextromethorphan hydrobromide 200/20 mg/ 10 mL
Directions
- do not exceed the maximum recommended daily dose in a 24 hour period
- shake well before use
Age (yr) | Dose (mL) |
adults and children 12 years and over | 10 mL every 4 hours Max dose is 60 mL in 24 hr |
children under 12 years | Ask a doctor |
Guaifenesin Dextromethorphan hydrobromide 200/20 mg/10 mL
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)
Guaifenesin Dextromethorphan hydrobromide 200/20 mg/10 mL
Warnings
Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) or for 2 weeks after stopping the MAOI drug.
Ask a doctor before use if you have
- cough that occurs with too much phlegm (mucus)
- cough that lasts or is chronic such as occurs with smoking, asthma, chronic bronchitis, or emphysema
_________________________________________________________________
Ask a doctor or pharmacist before use if you are taking any other drug. ___________________________________________________________________
- Stop use and ask a doctor if
- your cough lasts more than 7 days, comes back, or is accompanied by fever, rash or persistent headache.
- you are hypersensitive to any of the ingredients
___________________________________________________________________
If pregnant or breast-feeding, ask a health professional before use.
Guaifenesin Dextromethorpan hydrobromide 200/20 mg/10 mL
Inactive ingredients citric acid, glycerin, propylene glycol, purified water, saccharin sodium, sodium benzoate, sorbitol, sucralose, xanthan gum
Guaifenesin Dextromethorphan hydrobromide 200/20 mg/10 mL
Uses
- helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive
- temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold.
Guaifenesin Dextromethorphan hydrobromide 200/20 mg/10 mL
Active ingredients (in each 10 mL cup)
Guaifenesin 200 mg
Dextromethorphan hydrobromide 20 mg
Guaifenesin Dextromethorphan hydrobromide 200/20 mg/ 10 mL
Purpose
Expectorant
Cough Suppressant
Guaifenesin Dextromethorphan hydrobromide 200/20 mg/ 10 mL
Other information
- each 10 mL contains: sodium 40 mg
- store at 20-25°C (68-77°F)
- protect from excessive moisture
- do not use if lid seal is open or damaged
- sugar free, dye free, alcohol free
- see bottom of cup for lot number and expiration date
Guaifenesin Dextromethorphan hydrobromide 200/20 mg/10 mL
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0904-6844-70 | 2022-09-23 | C162847 | 48780-1 | e4f33bdf-ac2e-d8a0-e053-dadaa90a6e4e | Major Pharmaceuticals Unit Dose OTC Monograph Guaifenesin DM 200/20 mg/ 10 mL Guaifenesin DM 100/10 mg/ 5 mL |
| 0904-6980-72 | 2022-09-23 | C162847 | 48780-1 | e4f33bdf-ac2e-d8a0-e053-dadaa90a6e4e | Major Pharmaceuticals Unit Dose OTC Monograph Guaifenesin DM 200/20 mg/ 10 mL Guaifenesin DM 100/10 mg/ 5 mL |
| 0904-6844-70 | 2022-07-29 | C162847 | 48780-1 | e4f33bdf-ac2e-d8a0-e053-dadaa90a6e4e | Major Pharmaceuticals Unit Dose OTC Monograph Guaifenesin DM 200/20 mg/ 10 mL Guaifenesin DM 100/10 mg/ 5 mL |
| 0904-6980-72 | 2022-07-29 | C162847 | 48780-1 | e4f33bdf-ac2e-d8a0-e053-dadaa90a6e4e | Major Pharmaceuticals Unit Dose OTC Monograph Guaifenesin DM 200/20 mg/ 10 mL Guaifenesin DM 100/10 mg/ 5 mL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0904-6980-72 | ML - Milliliter | 0904-6980 | 2f347743-4687-4407-8145-03a168ab2cf6 | 1 | 2019-10-07 |
| 0904-6844-70 | ML - Milliliter | 0904-6844 | 8fa8728c-7ade-4e15-a52a-eb965f8c5d46 | 1 | 2019-10-07 |
Products#
Every source-derived product name is available through these pages.
- Guaifenesin and Dextromethorphan Oral Solution
- Guaifenesin Dextromethorphan hydrobromide Oral Solution
- DEXTROMETHORPHAN HYDROBROMIDE
- DEXTROMETHORPHAN
- SUCRALOSE
- XANTHAN GUM
- GLYCERIN
- GUAIFENESIN
- ANHYDROUS CITRIC ACID
- PROPYLENE GLYCOL
- SACCHARIN SODIUM
- SACCHARIN
- SORBITOL
- SODIUM BENZOATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 0904-6980 | 0904-6980-72 |
| 0904-6844 | 0904-6844-70 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| e95ec98e-1a24-ddd9-e053-2a95a90af95e | 9247ea9f-3df1-ef4c-e053-2995a90aab15 | 2022-09-23 | Warnings | 9247ea9f-3df1-ef4c-e053-2995a90aab15 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.




